VitalTech Debuts VitalTech Insights
/PRNewswire/ -- VitalTech, a rapidly growing market leader in enterprise virtual care solutions, announced today the release of VitalTech Insights, a business...
Source: prnewswire.com
Patient Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patient Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patient Analysis Today - Breaking & Trending Today
Global Diabetes Care Devices Markets, 2021-2022 & 2028 - Growing Demand for Non-Invasive Glucose Monitoring Devices & Product Innovations in Diabetes Care
/PRNewswire/ -- The "Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin...
Source: prnewswire.com
:strip_icc():format(jpeg)/kly-media-production/medias/3276910/original/022346100_1603514648-STAT_MS_Sanofi_AP_19147232119964-1600x900.jpg)
WHO Rekomendasikan Obat dari Roche, Sanofi untuk Kurangi Risiko Kematian Akibat COVID-19
WHO Rekomendasikan Obat dari Roche, Sanofi untuk Kurangi Risiko Kematian Akibat COVID-19 Diperbarui 07 Jul 2021, 06:53 WIB 11 Logo Sanofi. (KRISTOFFER TRIPPLAAR/SIPA VIA AP IMAGES) Liputan6.com, Jakarta - Organisasi Kesehatan Dunia (WHO) merekomendasikan penggunaan obat Actemra dari perusahaan obat-obatan Roche, dan Kevzara dari perusahaan Sanofi dengan kortikosteroid untuk pasien COVID-19. Rekomendasi itu keluar setelah data dari sekitar 11.000 pasien COVID-19 menunjukkan bahwa obat tersebut mengurangi risiko kematian. Baca Juga The Straits Times, Rabu (7/7/2021). Sebuah tim WHO mengevaluas...
Source: liputan6.com